A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease. CommentaryHOCKENBERY, David M; CRUICKSHANK, Scott; BOUVIER, Michelle et al.Blood. 2007, Vol 109, Num 10, issn 0006-4971, 4117, 4557-4563 [8 p.]Article

Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteinsHALLER, Aurelia A; LAUER, Georg M; DUKE, Richard C et al.Vaccine. 2007, Vol 25, Num 8, pp 1452-1463, issn 0264-410X, 12 p.Article

Mutation-selective tumor remission with ras-targeted, whole yeast-based immunotherapyYINGNIAN LU; BELLGRAU, Donald; DWYER-NIELD, Lori D et al.Cancer research (Baltimore). 2004, Vol 64, Num 15, pp 5084-5088, issn 0008-5472, 5 p.Article